Proof-of-Concept Study of Pipamperone Added to Stable Treatment With Risperidone or Paliperidone in Chronic Schizophrenia

This study is currently recruiting participants.
Verified June 2012 by PharmaNeuroBoost N.V.
Sponsor:
Information provided by (Responsible Party):
PharmaNeuroBoost N.V.
ClinicalTrials.gov Identifier:
NCT01450514
First received: October 7, 2011
Last updated: June 6, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)